‏إظهار الرسائل ذات التسميات Tricog Health. إظهار كافة الرسائل
‏إظهار الرسائل ذات التسميات Tricog Health. إظهار كافة الرسائل

AI-driven Healthcare Analytics Firm Tricog Raises $10.5 Mn in Series B Funding

Tricog, one of the world’s largest healthcare analytics firms, has raised 10.5 million USD in Series B funding round from UTEC - The University of Tokyo Edge Capital, Japan; Aflac Ventures, LLC, Japan; TeamFund, USA and Dream Incubator, Japan. Existing investors Inventus Capital and Blume Ventures also participated in this round. 

The investment comes two years after Tricog’s Series A funding round, bringing the company’s total funding to 17.5 million USD. Since the previous round, Tricog has grown its presence in over 12 countries in South-East Asia and Africa. Tricog’s AI-powered platform has been used by over 3 million patients globally for wellness, screening and diagnosis of acute as well as chronic heart diseases. 

Founded in 2015 by Dr. Charit Bhograj, Dr. Zainul Charbiwala, Dr. Udayan Dasgupta and Abhinav Gujjar, Tricog leverages its deep medical and technology expertise, to provide Virtual Cardiology Services to remote clinics, powered by ground-breaking AI and medical experts. Tricog’sInstaECG platform has been deployed in over 2,500 Cathlabs, Hospitals, Clinics and Diagnostic Centres to help diagnose and manage patients with critical cardiac diseases including heart attacks. The platform has been deployed across both government and private health care networks and has demonstrated a significant reduction in mortality and morbidity.

Dr. CharitBhograj, CEO & Founder said, “We have witnessed phenomenal growth from our initial investments, both in terms of footprints in new geographies as well as revenue growth. Through this round of investment, we reinforce our commitment to strengthen our AI-powered platform for faster diagnosis, expand our product line and establish strong presence in Africa and Asia including India, China and Japan."

Tricog has recently launched the InstaEcho platform for remote echocardiography with a focus on using AI to enable Point of Care Cardiac Ultrasound for the diagnosis of Heart Failure, Valvular Heart disease and screening for Congenital Heart Disease. Tricog is also awaiting USFDA approval for its proprietary DeepRhythm platform for real-time patient monitoring.

Noriaki Sakamoto, Partner and Board Director, UTEC, Japan said: “Tricog is a shining illustration of a multidisciplinary deep-technology innovation originating in Asia while solving a large global unmet need.  As the lead investors of their Series A round in 2018, we were especially impressed with their scientific rigor, exemplary leadership, revenue prospects and commitment to saving lives. We are now proud to lead their Series B as well, and supplement Tricog with Japanese medical device partnerships and R&D collaborations."

Inventus Capital and Blume Ventures are the earliest investors in Tricog. ParagDhol, Director, Inventus Capital, said  “The Tricog team is amongst the most well-rounded we have backed. It is a privilege to have a ringside seat as Dr. Charit, Zainul, Udayan and Abhinav build out a classy healthcare technology company."

Sanjay Nath, Managing Partner at Blume Ventures, quoted “We’ve seen Tricog’s evolution from an India-based ECG healthcare startup to an integrated, AI-driven full-stack ‘virtual cardiologist’ platform. Most Indian B2B startups have traditionally focused on Enterprise/SaaS.  We’re proud to see DrCharit and the co-founding team at Tricog lead the way in building out deep-tech innovation, expanding product lines and creating impact by saving lives across developing markets globally".

YousufMazhar, Partner at TeamFund, an impact focused fund based in the US, said: “Tricog’s solution in low resource settings is a game changer by allowing not only instant ECG and Echo readings without a Cardiologist present, but also the ability to immediately detect life threatening situations such as heart attacks, allowing appropriate care to be administered in a timely manner."

Managing Director, Tomoyuki Shimada, Aflac Innovation Partners G.K. Japan, said, “It is an honor for Aflac Ventures, LLC. to invest in Tricog, an excellent professional team. We believe Tricog's approach using ECG plus AI should have a huge impact on our healthcare experience. As an insurance company, Aflac will seek possibilities collaborating with the Tricog team to achieve their mission and try to create opportunities in improving people's quality of life."

Health Care Analytics Company Tricog Health Raises Series A Funding

Bangalore-based Tricog Health Services has raised Series A funding from Inventus Capital Partners, Blume Ventures and a host of angel investors. The money will be used to further develop technology and market reach in their path breaking healthcare analytics platform.

Tricog Health was founded in January 2015 by a team of medical experts and technologists with an aim to help preserve people’s lives through technology. As per Dr Charit Bhograj, DM (Cardiology), Founder of CEO of Tricog, “In India alone, 5 million people suffer heart attacks every year and 3 million of these don’t survive. The average time it takes to diagnose a heart attack in urban India is 360 mins. The chances of survival with this delay is a mere 20%. If this delay were reduced to 90 min, the survival probability jumps to 80%. Tricog’s aim is to change that patient’s 80% chance of death to an 80% chance of staying alive.”

Tricog’s solution involves installing a cloud connected ECG machine in primary and secondary care medical centres - clinics, polyclinics, nursing homes and hospitals. The moment a doctor takes a patient’s ECG, the information is sent to their centrally located hub where a qualified expert is available 24/7. So every time an ECG is performed with Tricog’s cloud-connected ECG device, a Tricog specialist interprets it and sends the report through an SMS as well as a message on their mobile app.

Since start of operations in February 2015, Tricog has expanded to close to 250 clinics, nursing homes and hospitals in 12 cities and towns, both urban and rural. In this time, almost 100,000 patients were diagnosed, over 5000 of whom were found with acute heart conditions that required urgent intervention. Tricog would be expanding to cover all major cities and towns during 2016-17.

The key to scaling the service are machine learning and signal processing algorithms that ease the interpretation task for the doctors. “Advanced algorithms and data visualization help our expert doctors, ensuring accuracy and speed. The next step would be to unleash the potential for the algorithm to be used in personal health devices and wearable devices.” said Dr Charit.

“Machine learning, and associated technologies, are increasingly being deployed for large, multi-disciplinary, data intensive problems. The team we are backing at Tricog is amongst the most balanced we have come across at a Series A stage company. We look forward to partnering with the Tricog team to build a large and sustainable enterprise.” said Parag Dhol, Managing Director, Inventus.

Sanjay Nath, Managing Director of Blume had this to say about Tricog. "We were impressed by the very real pain point the experienced team at Tricog is solving - using technology to help save lives of patients facing cardiovascular disease. Tricog's deep data and algorithm-driven platform, augmented by a communicator (a proprietary hardware device manufactured by them) can reach patients in urban areas, Tier II and III cities, and even remote locations. Blume is excited to partner with Dr Charit and the Tricog team in their journey to be a 'virtual cardiologist', providing real-time and accurate diagnoses, and timely cardiovascular care to potentially millions of Indians."

Market Reports

Market Report & Surveys
IndianWeb2.com © all rights reserved